ARYL UREAS WITH ANGIOGENESIS INHIBITING ACTIVITY
This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ELTING JAMES HATOUM-MAKDAD HOLIA DUMAS JACQUES SCOTT WILLIAM J |
| description | This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2012289552A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2012289552A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2012289552A13</originalsourceid><addsrcrecordid>eNrjZDBwDIr0UQgNcnUMVgj3DPFQcPRz9_R3d_VzDfYMVvD08_B08gzx9HNXcHQO8QzzDInkYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZGRhaWpqZGjobGxKkCANyrJ3U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARYL UREAS WITH ANGIOGENESIS INHIBITING ACTIVITY</title><source>esp@cenet</source><creator>ELTING JAMES ; HATOUM-MAKDAD HOLIA ; DUMAS JACQUES ; SCOTT WILLIAM J</creator><creatorcontrib>ELTING JAMES ; HATOUM-MAKDAD HOLIA ; DUMAS JACQUES ; SCOTT WILLIAM J</creatorcontrib><description>This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121115&DB=EPODOC&CC=US&NR=2012289552A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121115&DB=EPODOC&CC=US&NR=2012289552A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ELTING JAMES</creatorcontrib><creatorcontrib>HATOUM-MAKDAD HOLIA</creatorcontrib><creatorcontrib>DUMAS JACQUES</creatorcontrib><creatorcontrib>SCOTT WILLIAM J</creatorcontrib><title>ARYL UREAS WITH ANGIOGENESIS INHIBITING ACTIVITY</title><description>This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBwDIr0UQgNcnUMVgj3DPFQcPRz9_R3d_VzDfYMVvD08_B08gzx9HNXcHQO8QzzDInkYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZGRhaWpqZGjobGxKkCANyrJ3U</recordid><startdate>20121115</startdate><enddate>20121115</enddate><creator>ELTING JAMES</creator><creator>HATOUM-MAKDAD HOLIA</creator><creator>DUMAS JACQUES</creator><creator>SCOTT WILLIAM J</creator><scope>EVB</scope></search><sort><creationdate>20121115</creationdate><title>ARYL UREAS WITH ANGIOGENESIS INHIBITING ACTIVITY</title><author>ELTING JAMES ; HATOUM-MAKDAD HOLIA ; DUMAS JACQUES ; SCOTT WILLIAM J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2012289552A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ELTING JAMES</creatorcontrib><creatorcontrib>HATOUM-MAKDAD HOLIA</creatorcontrib><creatorcontrib>DUMAS JACQUES</creatorcontrib><creatorcontrib>SCOTT WILLIAM J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ELTING JAMES</au><au>HATOUM-MAKDAD HOLIA</au><au>DUMAS JACQUES</au><au>SCOTT WILLIAM J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARYL UREAS WITH ANGIOGENESIS INHIBITING ACTIVITY</title><date>2012-11-15</date><risdate>2012</risdate><abstract>This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2012289552A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ARYL UREAS WITH ANGIOGENESIS INHIBITING ACTIVITY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A50%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ELTING%20JAMES&rft.date=2012-11-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2012289552A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |